OREX Financial Facts

Interest expense: -1.73M
Total revenues: 857K
See Full Income Statement

Total current liabilities: 24.57M
Deferred revenue, current portion: 3.43M
See Full Balance Sheet

Orexigen Therapeutics (OREX) Earnings

  |   Expand Research on OREX
Next EPS Date 11/12/14 *Est. EPS Growth Rate -10.5% *Last Qtr.
Average EPS % Beat Rate -4.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +7.0% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/7/14 Q214 -$0.21-$0.21 $0.00$857K$1M N/A Details
3/12/14 Q413 -$0.21-$0.19 -$0.02$857M$900M N/A Details
11/12/13 Q313 -$0.19-$0.18 -$0.01$857K$800K N/A Details
8/6/13 Q213 -$0.19-$0.19 $0.00N/A$900K N/A Details
3/13/13 Q412 -$0.41-$0.44 +$0.03$857K$910K N/A Details
11/7/12 Q312 -$0.44-$0.30 -$0.14$857K$890K N/A Details
8/7/12 Q212 -$0.25-$0.17 -$0.08$857K$890K N/A Details
5/9/12 Q112 -$0.16-$0.12 -$0.04$857K$900K N/A Details